Specifically, administration of either a PI3Kγ inhibitor or BTK inhibitor (ibrutinib) to PDAC-bearing mice repolarized TAMs towards a Th1 phenotype and led to CD8+ T cell cytotoxicity and reduced tumor burden. The gene discussed is BTK; the disease is neoplasm.